On April 1, 2020, Medifron DBT Co., Ltd. (KOSDAQ:A065650) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,885 KRW | +3.72% | -27.41% | -1.31% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,700 KRW | +1.89% | -4.09% | 98.14M | ||
1,445 KRW | +3.29% | +12.98% | 66.3M | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.31% | 202M | |
+10.55% | 67.6B | |
+11.64% | 18.21B | |
+9.40% | 13.37B | |
+16.53% | 9.94B | |
-32.90% | 5.74B | |
-10.98% | 5.57B | |
-4.09% | 4.91B | |
-4.83% | 4.87B | |
0.00% | 4.3B |
- Stock Market
- Equities
- A204620 Stock
- News Global Tax Free Co., Ltd.
- Medifron DBT Co., Ltd. announced that it has received KRW 10.999996728 billion in funding from Brain Contents CO., LTD., Swanicoco Co., Ltd., Global Tax Free Co., Ltd.